Skip to content

DSGN - Design Therapeutics, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchD

Design Therapeutics Inc

DSGN · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

D

DSGNDesign Therapeutics Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $17.25
52-wk low: $4.92
Prev close: $11.04
Mkt cap: $997.6M
Beta: 1.64
P/S: 29402.8x

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$111.5M

P7
Point72
Steven Cohen · Q2 2026 13F
$34.2M
position
QR
Qube Research
Q2 2026 13F

Earnings

Reported Aug 3, 2026

Earnings came in 11.1% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $998M

Valuation

P/S29402.82
P/B4.73

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: DSGN
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $997.55M
Beta: 1.64

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

4.7x

Profit margin

+0.0%

Op margin

+0.0%

ROE

-34.1%

$6.3M

position

JS

Jim Simons

Q2 2026 13F

$5.6M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for DSGN

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.32+11.1%

-$0.36 expected

Next report

What the street expects next

-34.1%

ROA-22.5%

Growth

Beta1.64